Drug Profile


Alternative Names: FTS-Zn; Nonathymulin; Thymalin; Thymic factor circulating; ZnFTS

Latest Information Update: 26 Mar 2009

Price : $50

At a glance

  • Originator Nonindustrial source; Santen Pharmaceutical
  • Class Oligopeptides; Thymus hormones
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Ischaemic heart disorders; Rheumatoid arthritis

Most Recent Events

  • 18 May 2004 Suspended - Preclinical for Rheumatoid arthritis in Japan (unspecified route)
  • 31 Dec 1999 No-Development-Reported for Rheumatoid arthritis in Japan (Unknown route)
  • 31 Dec 1995 No-Development-Reported for Rheumatoid arthritis in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top